Cargando…
A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker
In cancer biology, epithelial-to-mesenchymal transition (EMT) is associated with tumorigenesis, stemness, invasion, metastasis, and resistance to therapy. Evidence of co-expression of epithelial and mesenchymal markers suggests that EMT should be a stepwise process with distinct intermediate states...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226581/ https://www.ncbi.nlm.nih.gov/pubmed/32276404 http://dx.doi.org/10.3390/cancers12040906 |
_version_ | 1783534322283708416 |
---|---|
author | Godin, Louis Balsat, Cédric Van Eycke, Yves-Rémi Allard, Justine Royer, Claire Remmelink, Myriam Pastushenko, Ievgenia D’Haene, Nicky Blanpain, Cédric Salmon, Isabelle Rorive, Sandrine Decaestecker, Christine |
author_facet | Godin, Louis Balsat, Cédric Van Eycke, Yves-Rémi Allard, Justine Royer, Claire Remmelink, Myriam Pastushenko, Ievgenia D’Haene, Nicky Blanpain, Cédric Salmon, Isabelle Rorive, Sandrine Decaestecker, Christine |
author_sort | Godin, Louis |
collection | PubMed |
description | In cancer biology, epithelial-to-mesenchymal transition (EMT) is associated with tumorigenesis, stemness, invasion, metastasis, and resistance to therapy. Evidence of co-expression of epithelial and mesenchymal markers suggests that EMT should be a stepwise process with distinct intermediate states rather than a binary switch. In the present study, we propose a morphological approach that enables the detection and quantification of cancer cells with hybrid E/M states, i.e., which combine partially epithelial (E) and partially mesenchymal (M) states. This approach is based on a sequential immunohistochemistry technique performed on the same tissue section, the digitization of whole slides, and image processing. The aim is to extract quantitative indicators able to quantify the presence of hybrid E/M states in large series of human cancer samples and to analyze their relationship with cancer aggressiveness. As a proof of concept, we applied our methodology to a series of about a hundred urothelial carcinomas and demonstrated that the presence of cancer cells with hybrid E/M phenotypes at the time of diagnosis is strongly associated with a poor prognostic value, independently of standard clinicopathological features. Although validation on a larger case series and other cancer types is required, our data support the hybrid E/M score as a promising prognostic biomarker for carcinoma patients. |
format | Online Article Text |
id | pubmed-7226581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72265812020-05-18 A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker Godin, Louis Balsat, Cédric Van Eycke, Yves-Rémi Allard, Justine Royer, Claire Remmelink, Myriam Pastushenko, Ievgenia D’Haene, Nicky Blanpain, Cédric Salmon, Isabelle Rorive, Sandrine Decaestecker, Christine Cancers (Basel) Article In cancer biology, epithelial-to-mesenchymal transition (EMT) is associated with tumorigenesis, stemness, invasion, metastasis, and resistance to therapy. Evidence of co-expression of epithelial and mesenchymal markers suggests that EMT should be a stepwise process with distinct intermediate states rather than a binary switch. In the present study, we propose a morphological approach that enables the detection and quantification of cancer cells with hybrid E/M states, i.e., which combine partially epithelial (E) and partially mesenchymal (M) states. This approach is based on a sequential immunohistochemistry technique performed on the same tissue section, the digitization of whole slides, and image processing. The aim is to extract quantitative indicators able to quantify the presence of hybrid E/M states in large series of human cancer samples and to analyze their relationship with cancer aggressiveness. As a proof of concept, we applied our methodology to a series of about a hundred urothelial carcinomas and demonstrated that the presence of cancer cells with hybrid E/M phenotypes at the time of diagnosis is strongly associated with a poor prognostic value, independently of standard clinicopathological features. Although validation on a larger case series and other cancer types is required, our data support the hybrid E/M score as a promising prognostic biomarker for carcinoma patients. MDPI 2020-04-08 /pmc/articles/PMC7226581/ /pubmed/32276404 http://dx.doi.org/10.3390/cancers12040906 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Godin, Louis Balsat, Cédric Van Eycke, Yves-Rémi Allard, Justine Royer, Claire Remmelink, Myriam Pastushenko, Ievgenia D’Haene, Nicky Blanpain, Cédric Salmon, Isabelle Rorive, Sandrine Decaestecker, Christine A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker |
title | A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker |
title_full | A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker |
title_fullStr | A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker |
title_full_unstemmed | A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker |
title_short | A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker |
title_sort | novel approach for quantifying cancer cells showing hybrid epithelial/mesenchymal states in large series of tissue samples: towards a new prognostic marker |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226581/ https://www.ncbi.nlm.nih.gov/pubmed/32276404 http://dx.doi.org/10.3390/cancers12040906 |
work_keys_str_mv | AT godinlouis anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT balsatcedric anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT vaneyckeyvesremi anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT allardjustine anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT royerclaire anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT remmelinkmyriam anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT pastushenkoievgenia anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT dhaenenicky anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT blanpaincedric anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT salmonisabelle anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT rorivesandrine anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT decaesteckerchristine anovelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT godinlouis novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT balsatcedric novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT vaneyckeyvesremi novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT allardjustine novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT royerclaire novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT remmelinkmyriam novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT pastushenkoievgenia novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT dhaenenicky novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT blanpaincedric novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT salmonisabelle novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT rorivesandrine novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker AT decaesteckerchristine novelapproachforquantifyingcancercellsshowinghybridepithelialmesenchymalstatesinlargeseriesoftissuesamplestowardsanewprognosticmarker |